Biovigate adheres to GMP by implementing rigorous quality control systems, conducting regular audits, and continuous staff training. Our facilities are equipped with state-of-the-art technology, and we maintain detailed documentation to ensure traceability and accountability at every production stage.

Biovigate follows GMP guidelines as set by international regulatory bodies such as the FDA (Food and Drug Administration), EMA (European Medicines Agency), and WHO (World Health Organization). These guidelines encompass aspects like hygiene, documentation, process validation, and quality control.

GMP audits at Biovigate are conducted regularly by both internal and external auditors. Internal audits are carried out quarterly to ensure ongoing compliance, while external audits by regulatory bodies occur annually or as required.

Any deviations or non-conformities are promptly investigated through our CAPA (Corrective and Preventive Action) system. We identify the root cause, implement corrective actions, and monitor the effectiveness of these actions to prevent recurrence.

We stay informed through continuous professional development, participation in industry conferences, and active engagement with regulatory bodies. Our quality assurance team regularly reviews and updates our practices to align with the latest GMP standards.